Suchergebnisse - "Botson, John K."

PubPharm (19)

1

A Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase : 12-Month Findings

enthalten in: ACR open rheumatology | 2023

von Botson, J. | Saag, K. | Peterson, J. | +9

2

A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase : Primary Efficacy and Safety Findings

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2023

von Botson, J. | Saag, K. | Peterson, J. | +14

3

A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase:12‐Month Findings

enthalten in: ACR Open Rheumatology | 2023

von Botson, J. | Saag, K. | Peterson, J. | +9

4

A Randomized, Placebo‐Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase : Primary Efficacy and Safety Findings

enthalten in: Arthritis & Rheumatology | 2023

von Botson, J. | Saag, K. | Peterson, J. | +14

5

Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout : 12-month exploratory outcomes of the MIRROR open-label trial

enthalten in: Arthritis research & therapy | 2022

von Botson, J. | Obermeyer, K. | LaMoreaux, B. | +3

6

Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial

enthalten in: Arthritis Research & Therapy | 2022

von Botson, J. | Obermeyer, K. | LaMoreaux, B. | +3

7

Improved joint and patient-reported health assessments with pegloticase plus methotrexate co-therapy in patients with uncontrolled gout: 12-month exploratory outcomes of the MIRROR open-label trial

enthalten in: Arthritis Research & Therapy | 2022

von Botson, J. | Obermeyer, K. | LaMoreaux, B. | +3

8

Dual-energy CT assessment of rapid monosodium urate depletion and bone erosion remodelling during pegloticase plus methotrexate co-therapy

enthalten in: Rheumatology (Oxford, England) | 2022

von Dalbeth, N. | Becce, F. | Botson, J. | +2

9

A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR) : 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study

enthalten in: Arthritis research & therapy | 2022

von Botson, J. | Tesser, J. | Bennett, R. | +11

10

A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study

enthalten in: Arthritis Research & Therapy | 2022

von Botson, J. | Tesser, J. | Bennett, R. | +11